Osaka International Cancer Institute — Osaka, Osaka

Public research footprint of Osaka International Cancer Institute, compiled from the ClinicalTrials.gov public registry.

287

Registered studies

167

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Advanced or Metastatic Non-small Cell Lung Cancer · Prostate Cancer · PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or… · Locally Advanced Unresectable Gastroesophageal Junction (GEJ)…

Recently updated registry entries

NCT06816108 — A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors (Active Not Recruiting)
NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)
NCT07365241 — A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Osaka International Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.